FDA & Prescription Drugs

• Study Reveals High Levels of Lead In Lipstick

  Chrissie Cole | September 01, 2009 12:19 AM | 0 CommentsOrange County, CA

  Lead levels in lipstick are higher than previously reported according to a new study by the U.S. Food and Drug Administration (FDA). The agency tested 20 (unidentified brands) lipsticks and...

• Study to Analyze ADHD Medications and Heart Attack Risks

  Chrissie Cole | September 17, 2007 7:06 PM | 0 CommentsOrange County, CA

  A comprehensive new study is underway by two U.S. Department of Health and Human Services agencies, to determine if prescription medications used to treat attention deficit hyperactivity disorder (ADHD) increases the risk of heart attack, cardiovascular problems or stroke.Research supported by the U.S. Food and Drug Administration (FDA) and the Agency for Healthcare Research and Quality (AHRQ)...

• Reports of Adverse Drug Effects on the Rise

  Chrissie Cole | September 15, 2007 1:57 PM | 0 CommentsOrange County, CA

  According to a new study, reports of adverse drug affects reported to the Food and Drug Administration has doubled over the past decade. Deaths associated with serious adverse drug effects also doubled."A change of this magnitude ought to be cause for alarm," says Thomas J. Moore, senior scientist, drug safety and policy, for the Institute for Safe Medication Practices in Huntingdon Valley, Pa.,...

• Avandia Under Fire Again

  Chrissie Cole | September 12, 2007 2:41 PM | 0 CommentsOrange County, CA

  GlaxoSmithKline's (GSK) type2 diabetes drug Avandia, is once again the center of controversy after new research claims that using the drug increases the risk of heart attack. A research paper published in the Journal of the American Medical Association (JAMA) discovered that patient's who take Avandia, were 42 percent more likely to suffer a heart attack then those that were in the control...

• Certain Diabetes Drug Manufacturers to Heighten Label Warnings on Heart Failure Risk

  Chrissie Cole | August 15, 2007 9:13 PM | 0 CommentsOrange County, CA

  Manufacturers of certain drugs approved for treating Type 2 diabetes have agreed to add stronger warnings on the risk of heart failure, announced the U.S. Food and Drug Administration (FDA). The information will be included in a "boxed" warning - the FDA's strongest warning. The updated warning label will highlight that certain drugs may cause or worsen heart failure in some patients.The FDA...

• Data Shows Avandia Increases the Risk of Heart Attack

  Christina Cole | May 28, 2007 6:36 PM | 0 CommentsOrange County, CA

  Safety data from controlled clinical trials has shown a significant increase in the risk of heart attack and heart-related deaths in patients that are taking Avandia (rosiglitazone) for type 2 diabetes.However, there is other published and non published data from long term clinical trials that contradict the evidence about the risk of heart attack in patients currently taking Avandia.While the...

• FDA Says No to Vioxx Successor

  IB Contributor | May 05, 2007 7:31 PM | 0 CommentsOrange County, CA

  The U.S. Food and Drug Administration last week turned down pharmaceutical giant, Merck & Co.'s request to market Arcoxia, a successor to its banned arthritis drug Vioxx, according to an article posted on HealthDay's Web site. The decision came as little surprise, since an FDA advisory panel of medical experts had already voted 20-1 on April 12 against the approval of Arcoxia, a drug very...

• FDA Proposes Suicide Warnings on Antidepressants

  Christina Cole | May 02, 2007 8:52 PM | 0 CommentsOrange County, CA

  The FDA has requested that the makers of antidepressant drugs expand their warning labels to include adults age 18-24. The labels currently have similar warnings for adolescents and children.The maker of Prozac - Eli Lily Co and Pfizer Inc - Zoloft manufacturer and many other drug companies, said they will comply with the FDA's request."We believe this step will help ensure that the millions of...

• Permax (Pergolide) Withdrawn from Market

  Christina Cole | April 30, 2007 7:25 AM | 0 CommentsOrange County, CA

  The FDA in cooperation with the manufacturers that distribute Permax (pergolide), have agreed to withdraw the drug from the market due to potential heart valve damage. Two new studies showed that patients with Parkinson's disease that were treated using Permax (Pergolide) had an increased chance of serious damage to their heart valve. Permax is a member of a class of drugs that are known as...

• Dietary Supplement Joy of Love Recalled

  Christina Cole | April 19, 2007 12:46 PM | 0 CommentsOrange County, CA

  Jen-On Herbal Science International Inc. is voluntarily recalling one of their supplements sold under the name HS Joy of Love. The recall was announced after they were informed by the Food and Drug Administration (FDA) that lab analysis completed by the FDA, found the product contained Piperadion Vardenafil, an analog of Vardenafil, an FDA approved drug that is used for the treatment of male...